Trinity Biotech Files Routine 6-K, Confirms 20-F Annual Reporting

Ticker: TRIB · Form: 6-K · Filed: Feb 20, 2024 · CIK: 888721

Trinity Biotech PLC 6-K Filing Summary
FieldDetail
CompanyTrinity Biotech PLC (TRIB)
Form Type6-K
Filed DateFeb 20, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: SEC-filing, regulatory-compliance, foreign-issuer

TL;DR

**Trinity Biotech just filed a standard 6-K, confirming they report annually on Form 20-F.**

AI Summary

TRINITY BIOTECH PLC, a foreign private issuer, filed a Form 6-K with the SEC on February 20, 2024, for the month of February 2024. The filing indicates that the company files annual reports under Form 20-F. The principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.

Why It Matters

This routine filing confirms Trinity Biotech's compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors regarding its regulatory status.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain any new material financial or operational information that would introduce significant risk.

Key Players & Entities

  • TRINITY BIOTECH PLC (company) — Registrant
  • February 2024 (date) — Month of report
  • Form 20-F (document) — Annual report type
  • February 20, 2024 (date) — Filing date
  • IDA Business Park, Bray, Co. Wicklow, Ireland (location) — Principal Executive Office

FAQ

What type of SEC form did TRINITY BIOTECH PLC file?

TRINITY BIOTECH PLC filed a Form 6-K, which is a 'Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934'.

When was this 6-K form filed with the SEC?

The 6-K form was filed on February 20, 2024, with a conformed period of report of February 16, 2024.

Under which form does TRINITY BIOTECH PLC file its annual reports?

TRINITY BIOTECH PLC indicates that it files its annual reports under Form 20-F.

What is the principal executive office address for TRINITY BIOTECH PLC as stated in the filing?

The principal executive office address is IDA Business Park Bray, Co. Wicklow, Ireland.

Is TRINITY BIOTECH PLC submitting this Form 6-K in paper?

The filing indicates by un-checked boxes that the registrant is NOT submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or 101(b)(7).

Filing Stats: 391 words · 2 min read · ~1 pages · Grade level 12.8 · Accepted 2024-02-16 18:00:27

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Des Fitzgerald Des Fitzgerald Interim Chief Financial Officer Date:15 February, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.